Total Funding
62
52
Total FundingCorporate Round raised
Growth Score
-7 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
56681
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
Deep Singh: Head of R&D, Precision DeliveryPast Role: Alcyone Lifesciences, Program Manager
PJ Anand: President and CEOPast Role: Arsenal Medical, Executive Vice President of Corporate Development
About the Company
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities and overcome challenges for CNS therapy development.
